Category: Astrazeneca

Successful COVID-19 Vaccine Injury Claims Double In Three Months

Data obtained through freedom of information requests have revealed a rise in successful COVID-19 vaccine injury claims which has nearly doubled in three months. UK government payouts for the vaccine injured have now surpassed £11.5 million but could be even more. Under current rules, victims of COVID-19 vaccines in the UK are entitled to a…


Successful COVID-19 Vaccine Injury Claims Double in 3 Months

Data obtained through Freedom of Information (FOI) requests have revealed a rise in successful COVID-19 vaccine injury claims which has nearly doubled in three months. UK government payouts for the vaccine injured have now surpassed £11.5 million but could be even more. Under current rules, victims of COVID-19 vaccines in the UK are entitled to…


FDA Panel Backs Restricted Use of AstraZeneca’s Prostate Cancer Drug

A panel of U.S. Food and Drug Administration (FDA) advisers on Friday voted for the restricted use of British drugmaker AstraZeneca Plc.’s experimental treatment, jointly developed with Merck & Co., for a type of prostate cancer. The FDA panel voted 11–1 with one abstention, in favor of Lynparza, in combination with other medications—abiraterone and prednisone…


Coroner Confirms Earliest Known UK Death From AstraZeneca Vaccine

A coroner formally has officially recorded that the likely cause of Dr. Stephen Wright’s death was the AstraZeneca vaccine, making him potentially the first person in the UK to have died from the vaccine, according to his wife. More than two years after 32-year-old Stephen Wright, an NHS psychologist in south-east London, died, an inquest…


Major Countries Officially Report 100 Deaths Caused by COVID-19 Vaccines (Part 1)

While potentially fatal blood clots and heart inflammation have been acknowledged as rare side effects of the COVID-19 vaccines, there might be a more expansive field of potential adverse events across multiple body systems, suggest safety signals from the Vaccine Adverse Event Reporting System (VAERS), research reports, doctors’ observations, and the experiences of the vaccinated.   In…


Nearly 100 Deaths Caused by COVID-19 Vaccines: Government Data From Major Countries (Part 1)

While potentially fatal blood clots and heart inflammation have been acknowledged as rare side effects of the COVID-19 vaccines, there might be a more expansive field of potential adverse events across multiple body systems, suggest safety signals from the Vaccine Adverse Event Reporting System (VAERS), research reports, doctors’ observations, and the experiences of the vaccinated.   In…


Risk of Cardiac Death Tripled for Young Women Following AstraZeneca COVID-19 Vaccination: Study

The risk of sudden cardiac death in young women more than tripled following an AstraZeneca COVID-19 shot, according to a study using England’s official data published on Monday. Vahé Nafilyan, senior statistician at the Office for National Statistics (ONS), said researchers found “receiving a first dose of a non-mRNA vaccine was associated with an increased risk…


Senators Call for Release of COVID-19 Vaccine Agreements

Four Australian senators have lodged an order for the release of contracts between the federal government and pharmaceutical companies for the production of COVID-19 vaccines. The senators will lodge the motion on Nov. 29, 2022, for the current Labor health minister to release agreements with Pfizer, AstraZeneca, Moderna, and Novavax, including details on vaccine efficacy,…


Another Study Finds COVID-19 Vaccine Effectiveness Turns Negative Within Months

The effectiveness of the Pfizer and AstraZeneca COVID-19 vaccines turns negative against severe COVID-19 months after administration, according to a new study. A single dose of the Pfizer vaccine was pegged at negative 121 percent effectiveness on day 84 and negative 85 at day 98. A second Pfizer dose held up better, but still dipped…


AstraZeneca’s COVID Vaccine Suffers a Setback in Nasal Spray Trial

Attempts by Oxford University researchers and AstraZeneca Plc. to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection. An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which…